GVB-2001 Gene Therapy Via Intracameral Injection for the Treatment of Primary Open Angle Glaucoma

Clinical trial NCT06921317 · RECRUITING

Trial details

NCT number: NCT06921317
Sponsor: IVIEW Therapeutics Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Primary Open-Angle Glaucoma (POAG)

Start date: 2025-11-19
Primary completion: 2027-12-30
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.